TIGERMED (03347.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec4

CITIC Securities Fund Reduced 216,800 Shares of Taege 医药

11:20

Dec1

JPMorgan Cuts Stake in 泰格医药 by 831,247 Shares

12:46

Nov27

JPMorgan Increases Stake in Therapix Biosciences to 8.39%

11:17

Nov18

Cao Xiaochun Completes Share Reduction Plan at Theragen Medical

14:15

Nov8

HSBC Analyst Reiterates Buy Rating on TG Therapeutics H-Shares

00:32

Oct30

CLSA Maintains Tigermed's 'Outperform' Rating and Adjusts Target Price and Profit Projections

08:42

Schedules & Filings

Schedules

Filings

Oct28

Earning Release(CST)

FY2025 Q3 Earning Release (HKD) Revenue 1.941 B, Net Income 696.45 M, EPS 0.8016

Aug28

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 1.846 B, Net Income 238.46 M, EPS 0.2863

Jul11

Distribution Plan(CST)

Cash dividend 0.3245 HKD

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change